As approximately 15% of all colorectal cancers display microsatellite instability [22], these data suggest that in an unselected sample set, if PTEN mutation is found predominantly or entirely in MSI+ colorectal cancers, approximately 2-3% of all colorectal cancer samples may be expected to exhibit PTEN mutations. This evidence concerns the gene PTEN and colorectal cancer.